MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

EXCLUSIVE: Indie filmmaker Kevin Cate has wrapped on the Georgia production of his debut feature, the holiday road trip comedy Unbearable Christmas. Principal cast for the film includes Julia ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

QUÉBEC, April 3, 2025 /CNW/ - Synex Business Performance (Synex), a rapidly growing player in the independent insurance brokerage sector across Canada, is proud to welcome two renowned ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

UBS analyst Trung Huynh lowered the firm’s price target on Cabaletta Bio (CABA) to $7 from $10 and keeps a Buy rating on the shares. A new Gr3 ICANS case has been flagged, but appears to be ...

Northvolt AB today announced that it has filed for bankruptcy in Sweden. It says Northvolt North America is solvent, but what will happen to its massive EV battery plant project in Canada?

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Cabaletta Bio (CABA) to $13 from $26 and keeps a Buy rating on the shares. The firm notes that along with earnings, Cabaletta ...

CAMBRIDGE, Mass., March 11, 2025--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb ...